making good progress

making excellent progress 😄

We're excited to share the first publication from our novel #Hypothyroidism treatment, XP-8121, a once-weekly subcutaneous injection. Read more on the ASCPT Alexandria website: bit.ly/4mgfcaz​ ​ #InnovationInMedicine #DrugDevelopment #CompanyUpdate

Madrigal Receives Positive CHMP Opinion for Resmetirom (Rezdiffra™) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis $MDGL tinyurl.com/23vcdyb8

Instead of reading ‘hot takes’ about the Strait of Hummus by Fintwit influencers who had never heard of it until 10 days ago, do yourself a favor and read this well-reasoned piece by freight researcher Yiannis Parganas (Intermodal).

RFK Jr's thimerosal thread is a masterclass in misinformation. Let's fact-check it line by line. 🧵

BOTTOM LINE: When “evidence” relies on phantom papers, misquotes, 48‑year‑old Soviet data, and math that doesn’t add up - while ignoring results from millions of kids - you’re not doing science; you’re spreading misinformation. The IOM, CDC, FDA, WHO, and researchers from four

finally...

Assembly Biosciences Reports Positive Topline Results from Phase 1b Clinical Trial of Next-Generation Investigational Capsid Assembly Modulator ABI-4334 in Chronic Hepatitis B $ASMB tinyurl.com/23byg376

"Large amounts of money aren't made by buying what everybody likes—they're made by buying what everybody underestimates." — Howard Marks

Dyne Therapeutics Announces Pricing of $200.0 Million Public Offering of Common Stock $DYN tinyurl.com/27be763v

$VRNA a bit lame premium of 23.2% on yesterday's closing price, but from April at least a double / my no. 27 M&A (no. 2 this year). Hoping for more M&A for rest of 2025

$MDGL Receives Notice of Allowance from U.S. Patent and Trademark Office for New U.S. Patent Covering Rezdiffra. Provides Protection Through Sept. 2044; Will Be Listed in FDA’s Orange Book

Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Relutrigine for the Treatment of Seizures Associated with SCN2A and SCN8A Developmental and Epileptic Encephalopathies $PRAX tinyurl.com/yqk4l4uv

who could have guessed that $SRPT is a shady company... many on here were rightly skeptical

Komodo national park

Wow!!!!! Vinay Prasad departs FDA ⁦ statnews.com/2025/07/29/vin…

good riddance

Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited $MDGL tinyurl.com/2yr9zcco